GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Other Liabilities for Insurance Companies

Newron Pharmaceuticals SpA (XSWX:NWRN) Other Liabilities for Insurance Companies


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Other Liabilities for Insurance Companies?

Other Liabilities for Insurance Companies only applies to insurance companies.


Newron Pharmaceuticals SpA Business Description

Industry
Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson's disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Geographically the research and development activities are performed in Italy and the United States.
Executives
Dr. Ulrich Köstlin Supervisory Board
Non-exec. Director Luca Benatti Supervisory Board
Patrick Langlois Supervisory Board